查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2025年全球肝素原料药市场
市场调查报告书
商品编码
1783836

2025年全球肝素原料药市场

Global Heparin API Market Research Report 2025
出版日期: | 出版商: QYResearch | 英文 125 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2024年全球肝素原料药市场规模将达12.3亿美元。

预计到 2031 年，市场规模将达到 23 亿美元，预测期内（2025-2031 年）的复合年增长率为 7.77%。

北美肝素原料药市场预计将从 2025 年的 4.3149 亿美元成长到 2031 年的 6.7133 亿美元，在 2025 年至 2031 年的预测期内复合年增长率为 7.65%。

亚太地区肝素原料药市场预计将从 2025 年的 4.785 亿美元成长到 2031 年的 7.9946 亿美元，在 2025 年至 2031 年的预测期内复合年增长率为 8.93%。

欧洲肝素原料药市场预计将从 2025 年的 5.3757 亿美元增长到 2031 年的 8.0122 亿美元，预测期内（2025-2031 年）的复合年增长率为 6.88%。

全球主要的肝素原料药生产商包括深圳海普瑞药业、烟台东诚药业、辉瑞、Bioiberica、常州千红生物製药、南京健友生化製药、河北常山生化製药、青岛九龙生物製药、Opocrin、东营天东製药。全球前三大供应商将在2024年占据约38%的营收份额。

本报告旨在对全球肝素原料药市场进行全面的定量和定性分析，使读者能够制定业务和成长策略、评估市场竞争、分析其当前的市场地位并就肝素原料药做出明智的业务决策。

肝素原料药市场规模、估值及预测报告提供了2020年至2031年期间的销售数量（单位：十亿）和收益（单位：百万美元）的历史及预测数据，以2024年为基准年。该报告对全球肝素原料药市场进行了全面细分。报告还提供了按产品类型、应用和地区分類的市场规模，并列出了参与企业。

为了更深入了解市场，我们对竞争格局、主要竞争对手的概况及其市场排名进行了全面分析，并讨论了技术趋势和新产品开发。

本报告提供了肝素原料药製造商、新参与企业和相关企业按公司收益、类型、应用和地区分類的整个市场和细分市场的收益、销售量和平均价格资讯。

目录

第一章 肝素原料药市场概述

  • 产品定义
  • 肝素原料药种类
  • 肝素原料药依用途
  • 全球肝素原料药市场规模预测
  • 假设和限制

第二章肝素原料药市场竞争

第三章肝素原料药市场状况（按地区）

  • 2020 年、2024 年及 2031 年全球肝素原料药市场规模（按地区）
  • 2020-2031年全球肝素原料药销售额（按地区）
  • 2020-2031年全球肝素原料药收益（按地区）
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第四章 按类型划分

  • 全球肝素原料药销售额（按类型）（2020-2031）
  • 全球肝素原料药收益（按类型）（2020-2031）
  • 全球肝素原料药价格（依类型划分）（2020-2031年）

应用领域

  • 全球肝素原料药销售额（依应用）（2020-2031）
  • 全球肝素原料药收益（按应用类型划分）（2020-2031 年）
  • 全球肝素原料药价格（依应用） （2020-2031）

第五章主要企业简介

  • Shenzhen Hepalink Pharmaceutical
  • Yantai Dongcheng Pharmaceutical
  • Pfizer
  • Bioiberica
  • Changzhou Qianhong Biopharma
  • Nanjing King-friend Biochemical Pharmaceutical
  • Hebei Changshan Biochemical Pharmaceutical
  • Qingdao Jiulong Biopharmaceutical
  • Opocrin
  • Dongying Tiandong Pharmaceutical
  • Aspen Oss
  • Yino Pharma
  • Nanjing Xinbai Pharmaceutical
  • Hubei Enoray Biopharmaceutical
  • Cisen Pharmaceutical

第六章产业炼及销售管道分析

  • 肝素原料药产业链分析
  • 肝素钠原料药药供应分析
  • 肝素原料药生产模式及製程分析
  • 肝素原料药的销售与行销
  • 肝素原料药客户分析

第七章 肝素原料药市场动态

第八章 调查结果与结论

第九章调查方法与资料来源

The global Heparin API market was valued at US$ 1.23 billion in 2024 and is anticipated to reach US$ 2.30 billion by 2031, witnessing a CAGR of 7.77% during the forecast period 2025-2031.

North American market for Heparin API is estimated to increase from $ 431.49 million in 2025 to reach $ 671.33 million by 2031, at a CAGR of 7.65% during the forecast period of 2025 through 2031.

Asia-Pacific market for Heparin API is estimated to increase from $ 478.50 million in 2025 to reach $ 799.46 million by 2031, at a CAGR of 8.93% during the forecast period of 2025 through 2031.

Europe market for Heparin API is estimated to increase from $ 537.57 million in 2025 to reach $ 801.22 million by 2031, at a CAGR of 6.88% during the forecast period of 2025 through 2031.

The major global manufacturers of Heparin API include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioiberica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately 38% of the revenue.

This report aims to provide a comprehensive presentation of the global market for Heparin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin API.

The Heparin API market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heparin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Heparin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Shenzhen Hepalink Pharmaceutical
  • Yantai Dongcheng Pharmaceutical
  • Pfizer
  • Bioiberica
  • Changzhou Qianhong Biopharma
  • Nanjing King-friend Biochemical Pharmaceutical
  • Hebei Changshan Biochemical Pharmaceutical
  • Qingdao Jiulong Biopharmaceutical
  • Opocrin
  • Dongying Tiandong Pharmaceutical
  • Aspen Oss
  • Yino Pharma
  • Nanjing Xinbai Pharmaceutical
  • Hubei Enoray Biopharmaceutical
  • Cisen Pharmaceutical

Segment by Type

  • Heparin Sodium API
  • Heparin Calcium API

Segment by Application

  • UFH
  • LMWH

Consumption by Region

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of APAC
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Middle East
  • Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Heparin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Heparin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Table of Contents

1 Heparin API Market Overview

  • 1.1 Product Definition
  • 1.2 Heparin API by Type
    • 1.2.1 Global Heparin API Market Value Comparison by Type (2024 VS 2031)
    • 1.2.2 Heparin Sodium API
    • 1.2.3 Heparin Calcium API
  • 1.3 Heparin API by Application
    • 1.3.1 Global Heparin API Market Value by Application (2024 VS 2031)
    • 1.3.2 UFH
    • 1.3.3 LMWH
  • 1.4 Global Heparin API Market Size Estimates and Forecasts
    • 1.4.1 Global Heparin API Revenue 2020-2031
    • 1.4.2 Global Heparin API Sales 2020-2031
    • 1.4.3 Global Heparin API Market Average Price (2020-2031)
  • 1.5 Assumptions and Limitations

2 Heparin API Market Competition by Manufacturers

  • 2.1 Global Heparin API Sales Market Share by Manufacturers (2020-2025)
  • 2.2 Global Heparin API Revenue Market Share by Manufacturers (2020-2025)
  • 2.3 Global Heparin API Average Price by Manufacturers (2020-2025)
  • 2.4 Global Key Players of Heparin API, Industry Ranking, 2022 VS 2023 VS 2024
  • 2.5 Global Key Manufacturers of Heparin API, Manufacturing Sites & Headquarters
  • 2.6 Global Key Manufacturers of Heparin API, Product Type
  • 2.7 Global Key Manufacturers of Heparin API, Founded Date
  • 2.8 Global Heparin API Market Competitive Situation and Trends
    • 2.8.1 Global Heparin API Market Concentration Rate
    • 2.8.2 The Global 5 and 10 Largest Heparin API Players Market Share by Revenue
    • 2.8.3 Global Heparin API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Heparin API Market Scenario by Region

  • 3.1 Global Heparin API Market Size by Region: 2020 Versus 2024 Versus 2031
  • 3.2 Global Heparin API Sales by Region: 2020-2031
    • 3.2.1 Global Heparin API Sales by Region: 2020-2025
    • 3.2.2 Global Heparin API Sales by Region: 2026-2031
  • 3.3 Global Heparin API Revenue by Region: 2020-2031
    • 3.3.1 Global Heparin API Revenue by Region: 2020-2025
    • 3.3.2 Global Heparin API Revenue by Region: 2026-2031
  • 3.4 North America Heparin API Market Facts & Figures by Country
    • 3.4.1 North America Heparin API Market Size by Country: 2020 VS 2024 VS 2031
    • 3.4.2 North America Heparin API Sales by Country (2020-2031)
    • 3.4.3 North America Heparin API Revenue by Country (2020-2031)
    • 3.4.4 United States
    • 3.4.5 Canada
  • 3.5 Europe Heparin API Market Facts & Figures by Country
    • 3.5.1 Europe Heparin API Market Size by Country: 2020 VS 2024 VS 2031
    • 3.5.2 Europe Heparin API Sales by Country (2020-2031)
    • 3.5.3 Europe Heparin API Revenue by Country (2020-2031)
    • 3.5.4 Germany
    • 3.5.5 France
    • 3.5.6 U.K.
    • 3.5.7 Italy
    • 3.5.8 Spain
  • 3.6 Asia Pacific Heparin API Market Facts & Figures by Region
    • 3.6.1 Asia Pacific Heparin API Market Size by Region: 2020 VS 2024 VS 2031
    • 3.6.2 Asia Pacific Heparin API Sales by Region (2020-2031)
    • 3.6.3 Asia Pacific Heparin API Revenue by Region (2020-2031)
    • 3.6.4 China
    • 3.6.5 Japan
    • 3.6.6 India
  • 3.7 Latin America Heparin API Market Facts & Figures by Country
    • 3.7.1 Latin America Heparin API Market Size by Country: 2020 VS 2024 VS 2031
    • 3.7.2 Latin America Heparin API Sales by Country (2020-2031)
    • 3.7.3 Latin America Heparin API Revenue by Country (2020-2031)
    • 3.7.4 Mexico
    • 3.7.5 Brazil
  • 3.8 Middle East and Africa Heparin API Market Facts & Figures by Country
    • 3.8.1 Middle East and Africa Heparin API Market Size by Country: 2020 VS 2024 VS 2031
    • 3.8.2 Middle East and Africa Heparin API Sales by Country (2020-2031)
    • 3.8.3 Middle East and Africa Heparin API Revenue by Country (2020-2031)
    • 3.8.4 Middle East
    • 3.8.5 Africa

4 Segment by Type

  • 4.1 Global Heparin API Sales by Type (2020-2031)
    • 4.1.1 Global Heparin API Sales by Type (2020-2025)
    • 4.1.2 Global Heparin API Sales by Type (2026-2031)
    • 4.1.3 Global Heparin API Sales Market Share by Type (2020-2031)
  • 4.2 Global Heparin API Revenue by Type (2020-2031)
    • 4.2.1 Global Heparin API Revenue by Type (2020-2025)
    • 4.2.2 Global Heparin API Revenue by Type (2026-2031)
    • 4.2.3 Global Heparin API Revenue Market Share by Type (2020-2031)
  • 4.3 Global Heparin API Price by Type (2020-2031)

Segment by Application

  • 4.4 Global Heparin API Sales by Application (2020-2031)
    • 4.4.1 Global Heparin API Sales by Application (2020-2025)
    • 4.4.2 Global Heparin API Sales by Application (2026-2031)
    • 4.4.3 Global Heparin API Sales Market Share by Application (2020-2031)
  • 4.5 Global Heparin API Revenue by Application (2020-2031)
    • 4.5.1 Global Heparin API Revenue by Application (2020-2025)
    • 4.5.2 Global Heparin API Revenue by Application (2026-2031)
    • 4.5.3 Global Heparin API Revenue Market Share by Application (2020-2031)
  • 4.6 Global Heparin API Price by Application (2020-2031)

5 Key Company Profiled

  • 5.1 Shenzhen Hepalink Pharmaceutical
    • 5.1.1 Shenzhen Hepalink Pharmaceutical Corporation Information
    • 5.1.2 Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
    • 5.1.3 Shenzhen Hepalink Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.1.4 Shenzhen Hepalink Pharmaceutical Heparin API Products Offered
  • 5.2 Yantai Dongcheng Pharmaceutical
    • 5.2.1 Yantai Dongcheng Pharmaceutical Corporation Information
    • 5.2.2 Yantai Dongcheng Pharmaceutical Introduction and Business Overview
    • 5.2.3 Yantai Dongcheng Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.2.4 Yantai Dongcheng Pharmaceutical Heparin API Products Offered
  • 5.3 Pfizer
    • 5.3.1 Pfizer Corporation Information
    • 5.3.2 Pfizer Introduction and Business Overview
    • 5.3.3 Pfizer Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.3.4 Pfizer Heparin API Products Offered
  • 5.4 Bioiberica
    • 5.4.1 Bioiberica Corporation Information
    • 5.4.2 Bioiberica Introduction and Business Overview
    • 5.4.3 Bioiberica Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.4.4 Bioiberica Heparin API Products Offered
  • 5.5 Changzhou Qianhong Biopharma
    • 5.5.1 Changzhou Qianhong Biopharma Corporation Information
    • 5.5.2 Changzhou Qianhong Biopharma Introduction and Business Overview
    • 5.5.3 Changzhou Qianhong Biopharma Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.5.4 Changzhou Qianhong Biopharma Heparin API Products Offered
  • 5.6 Nanjing King-friend Biochemical Pharmaceutical
    • 5.6.1 Nanjing King-friend Biochemical Pharmaceutical Corporation Information
    • 5.6.2 Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
    • 5.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin API Products Offered
  • 5.7 Hebei Changshan Biochemical Pharmaceutical
    • 5.7.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information
    • 5.7.2 Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
    • 5.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin API Products Offered
  • 5.8 Qingdao Jiulong Biopharmaceutical
    • 5.8.1 Qingdao Jiulong Biopharmaceutical Corporation Information
    • 5.8.2 Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
    • 5.8.3 Qingdao Jiulong Biopharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.8.4 Qingdao Jiulong Biopharmaceutical Heparin API Products Offered
  • 5.9 Opocrin
    • 5.9.1 Opocrin Corporation Information
    • 5.9.2 Opocrin Introduction and Business Overview
    • 5.9.3 Opocrin Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.9.4 Opocrin Heparin API Products Offered
  • 5.10 Dongying Tiandong Pharmaceutical
    • 5.10.1 Dongying Tiandong Pharmaceutical Corporation Information
    • 5.10.2 Dongying Tiandong Pharmaceutical Introduction and Business Overview
    • 5.10.3 Dongying Tiandong Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.10.4 Dongying Tiandong Pharmaceutical Heparin API Products Offered
  • 5.11 Aspen Oss
    • 5.11.1 Aspen Oss Corporation Information
    • 5.11.2 Aspen Oss Introduction and Business Overview
    • 5.11.3 Aspen Oss Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.11.4 Aspen Oss Heparin API Products Offered
  • 5.12 Yino Pharma
    • 5.12.1 Yino Pharma Corporation Information
    • 5.12.2 Yino Pharma Introduction and Business Overview
    • 5.12.3 Yino Pharma Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.12.4 Yino Pharma Heparin API Products Offered
  • 5.13 Nanjing Xinbai Pharmaceutical
    • 5.13.1 Nanjing Xinbai Pharmaceutical Corporation Information
    • 5.13.2 Nanjing Xinbai Pharmaceutical Introduction and Business Overview
    • 5.13.3 Nanjing Xinbai Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.13.4 Nanjing Xinbai Pharmaceutical Heparin API Products Offered
  • 5.14 Hubei Enoray Biopharmaceutical
    • 5.14.1 Hubei Enoray Biopharmaceutical Corporation Information
    • 5.14.2 Hubei Enoray Biopharmaceutical Introduction and Business Overview
    • 5.14.3 Hubei Enoray Biopharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.14.4 Hubei Enoray Biopharmaceutical Heparin API Products Offered
  • 5.15 Cisen Pharmaceutical
    • 5.15.1 Cisen Pharmaceutical Corporation Information
    • 5.15.2 Cisen Pharmaceutical Introduction and Business Overview
    • 5.15.3 Cisen Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.15.4 Cisen Pharmaceutical Heparin API Products Offered

6 Industry Chain and Sales Channels Analysis

  • 6.1 Heparin API Industry Chain Analysis
  • 6.2 Heparin API Raw Material Supply Analysis
    • 6.2.1 Key Raw Materials
    • 6.2.2 Raw Materials Key Suppliers
  • 6.3 Heparin API Production Mode & Process Analysis
  • 6.4 Heparin API Sales and Marketing
    • 6.4.1 Heparin API Sales Channels
    • 6.4.2 Heparin API Distributors
  • 6.5 Heparin API Customer Analysis

7 Heparin API Market Dynamics

  • 7.1 Heparin API Industry Trends
  • 7.2 Heparin API Market Drivers
  • 7.3 Heparin API Market Challenges
  • 7.4 Heparin API Market Restraints

8 Research Findings and Conclusion

9 Methodology and Data Source

  • 9.1 Methodology/Research Approach
    • 9.1.1 Research Programs/Design
    • 9.1.2 Market Size Estimation
    • 9.1.3 Market Breakdown and Data Triangulation
  • 9.2 Data Source
    • 9.2.1 Secondary Sources
    • 9.2.2 Primary Sources
  • 9.3 Author Details
  • 9.4 Disclaimer 107

List of Tables

  • Table 1. Global Heparin API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
  • Table 2. Global Heparin API Market Value by Application (2024 VS 2031) & (US$ Million)
  • Table 3. Global Heparin API Market Competitive Situation by Manufacturers in 2024
  • Table 4. Global Heparin API Sales (Billion Units) of Key Manufacturers (2020-2025)
  • Table 5. Global Heparin API Sales Market Share by Manufacturers (2020-2025)
  • Table 6. Global Heparin API Revenue (US$ Million) by Manufacturers (2020-2025)
  • Table 7. Global Heparin API Revenue Share by Manufacturers (2020-2025)
  • Table 8. Global Market Heparin API Average Price (US$/Billion Units) of Key Manufacturers (2020-2025)
  • Table 9. Global Key Players of Heparin API, Industry Ranking, 2022 VS 2023 VS 2024
  • Table 10. Global Key Manufacturers of Heparin API, Manufacturing Sites & Headquarters
  • Table 11. Global Key Manufacturers of Heparin API, Product Type
  • Table 12. Global Key Manufacturers of Heparin API, Founded Date
  • Table 13. Global Manufacturers Market Concentration Ratio (CR5)
  • Table 14. Global Heparin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin API as of 2024)
  • Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Heparin API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
  • Table 17. Global Heparin API Sales by Region (2020-2025) & (Billion Units)
  • Table 18. Global Heparin API Sales Market Share by Region (2020-2025)
  • Table 19. Global Heparin API Sales by Region (2026-2031) & (Billion Units)
  • Table 20. Global Heparin API Sales Market Share by Region (2026-2031)
  • Table 21. Global Heparin API Revenue by Region (2020-2025) & (US$ Million)
  • Table 22. Global Heparin API Revenue Market Share by Region (2020-2025)
  • Table 23. Global Heparin API Revenue by Region (2026-2031) & (US$ Million)
  • Table 24. Global Heparin API Revenue Market Share by Region (2026-2031)
  • Table 25. North America Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 26. North America Heparin API Sales by Country (2020-2025) & (Billion Units)
  • Table 27. North America Heparin API Sales by Country (2026-2031) & (Billion Units)
  • Table 28. North America Heparin API Revenue by Country (2020-2025) & (US$ Million)
  • Table 29. North America Heparin API Revenue by Country (2026-2031) & (US$ Million)
  • Table 30. Europe Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 31. Europe Heparin API Sales by Country (2020-2025) & (Billion Units)
  • Table 32. Europe Heparin API Sales by Country (2026-2031) & (Billion Units)
  • Table 33. Europe Heparin API Revenue by Country (2020-2025) & (US$ Million)
  • Table 34. Europe Heparin API Revenue by Country (2026-2031) & (US$ Million)
  • Table 35. Asia Pacific Heparin API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 36. Asia Pacific Heparin API Sales by Region (2020-2025) & (Billion Units)
  • Table 37. Asia Pacific Heparin API Sales by Region (2026-2031) & (Billion Units)
  • Table 38. Asia Pacific Heparin API Revenue by Region (2020-2025) & (US$ Million)
  • Table 39. Asia Pacific Heparin API Revenue by Region (2026-2031) & (US$ Million)
  • Table 40. Latin America Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 41. Latin America Heparin API Sales by Country (2020-2025) & (Billion Units)
  • Table 42. Latin America Heparin API Sales by Country (2026-2031) & (Billion Units)
  • Table 43. Latin America Heparin API Revenue by Country (2020-2025) & (US$ Million)
  • Table 44. Latin America Heparin API Revenue by Country (2026-2031) & (US$ Million)
  • Table 45. Middle East and Africa Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 46. Middle East and Africa Heparin API Sales by Country (2020-2025) & (Billion Units)
  • Table 47. Middle East and Africa Heparin API Sales by Country (2026-2031) & (Billion Units)
  • Table 48. Middle East and Africa Heparin API Revenue by Country (2020-2025) & (US$ Million)
  • Table 49. Middle East and Africa Heparin API Revenue by Country (2026-2031) & (US$ Million)
  • Table 50. Global Heparin API Sales (Billion Units) by Type (2020-2025)
  • Table 51. Global Heparin API Sales (Billion Units) by Type (2026-2031)
  • Table 52. Global Heparin API Sales Market Share by Type (2020-2025)
  • Table 53. Global Heparin API Sales Market Share by Type (2026-2031)
  • Table 54. Global Heparin API Revenue (US$ Million) by Type (2020-2025)
  • Table 55. Global Heparin API Revenue (US$ Million) by Type (2026-2031)
  • Table 56. Global Heparin API Revenue Market Share by Type (2020-2025)
  • Table 57. Global Heparin API Revenue Market Share by Type (2026-2031)
  • Table 58. Global Heparin API Price (US$/Billion Units) by Type (2020-2025)
  • Table 59. Global Heparin API Price (US$/Billion Units) by Type (2026-2031)
  • Table 60. Global Heparin API Sales (Billion Units) by Application (2020-2025)
  • Table 61. Global Heparin API Sales (Billion Units) by Application (2026-2031)
  • Table 62. Global Heparin API Sales Market Share by Application (2020-2025)
  • Table 63. Global Heparin API Sales Market Share by Application (2026-2031)
  • Table 64. Global Heparin API Revenue (US$ Million) by Application (2020-2025)
  • Table 65. Global Heparin API Revenue (US$ Million) by Application (2026-2031)
  • Table 66. Global Heparin API Revenue Market Share by Application (2020-2025)
  • Table 67. Global Heparin API Revenue Market Share by Application (2026-2031)
  • Table 68. Global Heparin API Price (US$/Billion Units) by Application (2020-2025)
  • Table 69. Global Heparin API Price (US$/Billion Units) by Application (2026-2031)
  • Table 70. Shenzhen Hepalink Pharmaceutical Corporation Information
  • Table 71. Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
  • Table 72. Shenzhen Hepalink Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 73. Shenzhen Hepalink Pharmaceutical Heparin API Product
  • Table 74. Yantai Dongcheng Pharmaceutical Corporation Information
  • Table 75. Yantai Dongcheng Pharmaceutical Introduction and Business Overview
  • Table 76. Yantai Dongcheng Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 77. Yantai Dongcheng Pharmaceutical Heparin API Product
  • Table 78. Pfizer Corporation Information
  • Table 79. Pfizer Introduction and Business Overview
  • Table 80. Pfizer Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 81. Pfizer Heparin API Product
  • Table 82. Bioiberica Corporation Information
  • Table 83. Bioiberica Introduction and Business Overview
  • Table 84. Bioiberica Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 85. Bioiberica Heparin API Product
  • Table 86. Changzhou Qianhong Biopharma Corporation Information
  • Table 87. Changzhou Qianhong Biopharma Introduction and Business Overview
  • Table 88. Changzhou Qianhong Biopharma Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 89. Changzhou Qianhong Biopharma Heparin API Product
  • Table 90. Nanjing King-friend Biochemical Pharmaceutical Corporation Information
  • Table 91. Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
  • Table 92. Nanjing King-friend Biochemical Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 93. Nanjing King-friend Biochemical Pharmaceutical Heparin API Product
  • Table 94. Hebei Changshan Biochemical Pharmaceutical Corporation Information
  • Table 95. Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
  • Table 96. Hebei Changshan Biochemical Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 97. Hebei Changshan Biochemical Pharmaceutical Heparin API Product
  • Table 98. Qingdao Jiulong Biopharmaceutical Corporation Information
  • Table 99. Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
  • Table 100. Qingdao Jiulong Biopharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 101. Qingdao Jiulong Biopharmaceutical Heparin API Product
  • Table 102. Opocrin Corporation Information
  • Table 103. Opocrin Introduction and Business Overview
  • Table 104. Opocrin Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 105. Opocrin Heparin API Product
  • Table 106. Dongying Tiandong Pharmaceutical Corporation Information
  • Table 107. Dongying Tiandong Pharmaceutical Introduction and Business Overview
  • Table 108. Dongying Tiandong Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 109. Dongying Tiandong Pharmaceutical Heparin API Product
  • Table 110. Aspen Oss Corporation Information
  • Table 111. Aspen Oss Introduction and Business Overview
  • Table 112. Aspen Oss Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 113. Aspen Oss Heparin API Product
  • Table 114. Yino Pharma Corporation Information
  • Table 115. Yino Pharma Introduction and Business Overview
  • Table 116. Yino Pharma Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 117. Yino Pharma Heparin API Product
  • Table 118. Nanjing Xinbai Pharmaceutical Corporation Information
  • Table 119. Nanjing Xinbai Pharmaceutical Introduction and Business Overview
  • Table 120. Nanjing Xinbai Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 121. Nanjing Xinbai Pharmaceutical Heparin API Product
  • Table 122. Hubei Enoray Biopharmaceutical Corporation Information
  • Table 123. Hubei Enoray Biopharmaceutical Introduction and Business Overview
  • Table 124. Hubei Enoray Biopharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 125. Hubei Enoray Biopharmaceutical Heparin API Product
  • Table 126. Cisen Pharmaceutical Corporation Information
  • Table 127. Cisen Pharmaceutical Introduction and Business Overview
  • Table 128. Cisen Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 129. Cisen Pharmaceutical Heparin API Product
  • Table 130. Key Raw Materials Lists
  • Table 131. Raw Materials Key Suppliers Lists
  • Table 132. Heparin API Distributors List
  • Table 133. Heparin API Customers List
  • Table 134. Heparin API Market Trends
  • Table 135. Heparin API Market Drivers
  • Table 136. Heparin API Market Challenges
  • Table 137. Heparin API Market Restraints
  • Table 138. Research Programs/Design for This Report
  • Table 139. Key Data Information from Secondary Sources
  • Table 140. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Product Picture of Heparin API
  • Figure 2. Global Heparin API Market Value Comparison by Type (2020-2031) & (US$ Million)
  • Figure 3. Global Heparin API Revenue Market Share by Type: 2024 & 2031
  • Figure 4. Heparin Sodium API Product Picture
  • Figure 5. Heparin Calcium API Product Picture
  • Figure 6. Global Heparin API Market Value by Application (2020-2031) & (US$ Million)
  • Figure 7. Global Heparin API Revenue Market Share by Application: 2024 & 2031
  • Figure 8. UFH
  • Figure 9. LMWH
  • Figure 10. Global Heparin API Revenue, (US$ Million), 2020 VS 2024 VS 2031
  • Figure 11. Global Heparin API Market Size (2020-2031) & (US$ Million)
  • Figure 12. Global Heparin API Sales (2020-2031) & (Billion Units)
  • Figure 13. Global Heparin API Average Price (US$/Billion Units) & (2020-2031)
  • Figure 14. Heparin API Report Years Considered
  • Figure 15. Global 5 and 10 Largest Heparin API Players: Market Share by Revenue in Heparin API in 2024
  • Figure 16. Heparin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): in 2024
  • Figure 17. Global Heparin API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
  • Figure 18. United States Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 19. Canada Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 20. Germany Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 21. France Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 22. U.K. Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 23. Italy Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 24. Spain Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 25. China Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 26. Japan Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 27. India Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 28. Mexico Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 29. Brazil Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 30. Middle East Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 31. Africa Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 32. Global Sales Market Share of Heparin API by Type (2020-2031)
  • Figure 33. Global Revenue Market Share of Heparin API by Type (2020-2031)
  • Figure 34. Global Sales Market Share of Heparin API by Application (2020-2031)
  • Figure 35. Global Revenue Market Share of Heparin API by Application (2020-2031)
  • Figure 36. Heparin API Value Chain
  • Figure 37. Number of Pigs Worldwide from 2012 to 2025 (in million head)
  • Figure 38. Number of Pigs Worldwide in 2025, by Leading Country (in million head)
  • Figure 39. Heparin API Production Process
  • Figure 40. Channels of Distribution
  • Figure 41. Bottom-up and Top-down Approaches for This Report
  • Figure 42. Data Triangulation
  • Figure 43. Key Executives Interviewed